Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs (Q41072880)

26 September 2017

title

Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1191576

30 August 2022

Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

1 reference

P. M. Mannucci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1191576

30 August 2022

M. Aberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1191576

30 August 2022

I. M. Nilsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1191576

30 August 2022

B. Robertson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1191576

30 August 2022

language of work or name

English

0 references

publication date

1 May 1975

1 reference

full work available at URL

26 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1975.tb00521.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1975.tb00521.x/fullpdf

25 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

British Journal of Haematology

25 October 2023

published in

1 reference

26 September 2017

volume

30

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

81-93

1 reference

Mutichannel system for the automatic recording of clot lysis

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

Methodological study and a recommended technique for determining the euglobulin lysis time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

The rise in clotting factor 8 induced in man by adrenaline: effect of alpha- and beta-blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

Fibrinolytic activity of human veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

THE EFFECT OF SOME PHYSIOLOGICAL STIMULI ON FIBRINOLYTIC ACTIVITY IN MAN MEASURED BY THE HEPARIN FRACTIONATION METHOD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

Dinoflagellates near the Cretaceous Jurassic Boundary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

Estimation of Nuclear Explosion Energies from Microbarograph Records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1975.TB00521.X

Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Effects of 8-lysine-vasopressin and synthetic analogues of release of ACTH.

25 October 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Kidney antihemophilic factor. Partial purification and some properties

25 October 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Effects of vasopressin and prostaglandin E 1 on the adenyl cyclase-cyclic 3',5'-adenosine monophosphate system of the renal medulla of the rat.

25 October 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Observations on fibrinolysis; experimental activity produced by exercise or adrenaline.

25 October 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

On the controlling function of the kidneys in fibrinolysis

25 October 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

The Fibrinolytic Response to Moderate Exercise and Intravenous Adrenaline in the Same Subjects

25 October 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Adrenergic mechanisms in the systemic plasminogen active response to adrenaline in man

25 October 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin

25 October 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Storage, release, and synthesis of coagulation factors in isolated perfused organs

25 October 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory Studies

25 October 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

A new vasopressin analogue and fibrinolysis

25 October 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Fibrinolysis induced by pressor amines

25 October 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

The combined estimation of cortisol and 11-desoxycortisol in plasma as Porter-Silber chromogens

25 October 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Clinical experience with determination of fibrinogen degradation products

25 October 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity

25 October 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

24

18

298

Holemans R.

1967

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A.

25 October 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Two Genetic Variants of von Willebrand's Disease

25 October 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy

25 October 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Increase in antihaemophilic globulin activity following infusion of adrenaline

25 October 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Blood-Coagulation Factor VIII: Genetics, Physiological Control, and Bioassay

25 October 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Alterations of fibrinolysis and blood coagulation

25 October 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Effect of prednisolone on the coagulation and fibrinolytic systems

25 October 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

34

22

211

Isacson S.

1969

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Effect of Treatment with Combined Phenformin and Ethyloestrenol on the Coagulation and Fibrinolytic Systems

25 October 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

Federation Proceedings

37

25

719

Krishna G.

1966

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Enhancement of plasminogen activator by vasopressin and adrenaline: a role of cyclic AMP?

25 October 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

European Journal of Clinical Investigation

25 October 2023

39

3

253

Mannucci P.M.

1973

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Nervous regulation of factor-VIII levels in man

25 October 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Role of the kidney in fibrinolytic activity of blood

25 October 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time.

25 October 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

46

20

397

Nilsson I.M.

1968

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

48

20

247

Pandolfi M.

1968

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

A method for determining serum inhibitors of plasminogen activation

25 October 2023

49

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

The histological localisation of fibrinolysin activator

25 October 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Purification of human antihemophilic factor (factor VIII) by gel chromatography

25 October 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus

25 October 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Methods for the evaluation of human fibrinolysis; studies with two combined technics

25 October 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Influence of some vasoactive drugs on fibrinolytic activity

25 October 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

Occurrence of fibrinolytic activity following administration of incotinic acid

25 October 2023

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1975.TB00521.X

25 October 2023

Identifiers

1 reference

26 September 2017

1 reference